| P50 | author | André Padilla | Q56417154 |
| | Gilles Labesse | Q70937731 |
| P2093 | author name string | Sylvie Pochet | |
| | Pierre Alexandre Kaminski | |
| | Claire Amiable | |
| P2860 | cites work | Tumor induction by the c-Myc target genes rcl and lactate dehydrogenase A. | Q53403867 |
| | Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors | Q81827035 |
| | Identification of Direct Protein Targets of Small Molecules | Q21558640 |
| | Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene | Q24336084 |
| | Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer | Q24642847 |
| | Solution structure of RCL, a novel 2'-deoxyribonucleoside 5'-monophosphate N-glycosidase | Q27657250 |
| | Structural characterization of the mammalian deoxynucleotide N-hydrolase Rcl and its stabilizing interactions with two inhibitors | Q27657759 |
| | Structure of the oncoprotein Rcl bound to three nucleotide analogues | Q27683947 |
| | Coot: model-building tools for molecular graphics | Q27860505 |
| | Molecular replacement with MOLREP | Q27860539 |
| | PRODRG: a tool for high-throughput crystallography of protein-ligand complexes | Q27860633 |
| | Refinement of macromolecular structures by the maximum-likelihood method | Q27861011 |
| | Adenosine deaminase-like protein 1 (ADAL1): characterization and substrate specificity in the hydrolysis of N(6)- or O(6)-substituted purine or 2-aminopurine nucleoside monophosphates | Q28115367 |
| | Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression | Q28272474 |
| | Biochemical properties of the nucleoside of 3-amino-1, 5-dihydro-5-methyl-1,4,5,6,8-pentaazaacenaphthylene (NSC-154020) | Q28329996 |
| | The c-Myc target gene Rcl (C6orf108) encodes a novel enzyme, deoxynucleoside 5'-monophosphate N-glycosidase | Q28575753 |
| | Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity | Q33330327 |
| | Clickable NAD analogues for labeling substrate proteins of poly(ADP-ribose) polymerases | Q33990380 |
| | A small molecule screening strategy with validation on human leukemia stem cells uncovers the therapeutic efficacy of kinetin riboside | Q34097005 |
| | Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT. | Q34127007 |
| | Purification and separation of pyridine nucleotide-linked dehydrogenases by affinity chromatography techniques | Q35112124 |
| | Mechanisms of apoptosis induction by nucleoside analogs. | Q35603389 |
| | The experimental chemotherapeutic N6-furfuryladenosine (kinetin-riboside) induces rapid ATP depletion, genotoxic stress, and CDKN1A(p21) upregulation in human cancer cell lines | Q37130026 |
| | E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction | Q37159065 |
| | Extent of enthalpy-entropy compensation in protein-ligand interactions. | Q38666534 |
| | Effects of kinetin riboside on proliferation and proapoptotic activities in human normal and cancer cell lines | Q39564350 |
| | N⁶-Alkyladenosines: Synthesis and evaluation of in vitro anticancer activity. | Q39638207 |
| | Antiproliferative activity of N6-isopentenyladenosine on MCF-7 breast cancer cells: cell cycle analysis and DNA-binding study | Q39659158 |
| | Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells. | Q39673619 |
| | Inhibitory effect of kinetin riboside in human heptamoa, HepG2. | Q39905351 |
| | N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1. | Q39908540 |
| | Kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells. | Q40030246 |
| | Transport, Phosphorylation, and Toxicity of a Tricyclic Nucleoside in Cultured Novikoff Rat Hepatoma Cells and Other Cell Lines and Release of Its Monophosphate by the Cells 2 | Q40034426 |
| | Preparation, biological activity and endogenous occurrence of N6-benzyladenosines | Q40147923 |
| | N6-isopentenyladenosine: a potential therapeutic agent for a variety of epithelial cancers | Q40170350 |
| | Probing the active site of the deoxynucleotide N-hydrolase Rcl encoded by the rat gene c6orf108. | Q41467386 |
| | Some short-chain N6-substituted adenosine analogues with antitumor properties | Q42273810 |
| | Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. | Q42681771 |
| | Anticancer activity of natural cytokinins: a structure-activity relationship study | Q43018195 |
| | Caspase inhibition and N6-benzyladenosine-induced apoptosis in HL-60 cells | Q43825440 |
| | Apoptosis induced by N6-substituted derivatives of adenosine is related to intracellular accumulation of corresponding mononucleotides in HL-60 cells | Q46718679 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e80755 | |
| P577 | publication date | 2013-11-19 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | N (6)-substituted AMPs inhibit mammalian deoxynucleotide N-hydrolase DNPH1 | |
| P478 | volume | 8 | |